NICE first rejected Kadcyla back in 2014, saying its cost of around £91,000 per patient at full price was too high, and that a small discount was not enough for it to be considered cost effective.

The price you pay for Kadcyla may depend on several factors. These include your dosage and whether you have health insurance. Financial assistance may be available to help with Kadcyla’s cost.

Kadcyla was one of the most expensive drugs on the CDF, costing up to £65,000 per patients, and charity Breast Cancer Now took the unusual step of calling on Roche to lower its price.